97 related articles for article (PubMed ID: 16405922)
1. Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells.
Li L; Lu Q; Shen Y; Hu X
Biochem Pharmacol; 2006 Feb; 71(5):584-95. PubMed ID: 16405922
[TBL] [Abstract][Full Text] [Related]
2. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
3. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo.
Xu Y; Liu Z; Sun J; Pan Q; Sun F; Yan Z; Hu X
PLoS One; 2011; 6(12):e28335. PubMed ID: 22164272
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1.
Sun M; Xu X; Lu Q; Pan Q; Hu X
Cancer Lett; 2007 Feb; 246(1-2):300-7. PubMed ID: 16621244
[TBL] [Abstract][Full Text] [Related]
5. Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin.
Wang S; Wang A; Shao M; Lin L; Li P; Wang Y
Sci Rep; 2017 Aug; 7(1):8419. PubMed ID: 28827665
[TBL] [Abstract][Full Text] [Related]
6. Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling.
Thandavarayan RA; Giridharan VV; Arumugam S; Suzuki K; Ko KM; Krishnamurthy P; Watanabe K; Konishi T
PLoS One; 2015; 10(3):e0119214. PubMed ID: 25742619
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and inhibit associated changes in Ca2+-induced mitochondrial permeability transition and mitochondrial membrane potential in H9c2 cardiomyocytes.
Chiu PY; Luk KF; Leung HY; Ng KM; Ko KM
Life Sci; 2008 May; 82(21-22):1092-101. PubMed ID: 18452952
[TBL] [Abstract][Full Text] [Related]
8. Schisandrin B inhibits cell proliferation and induces apoptosis in human cholangiocarcinoma cells.
Yang X; Wang S; Mu Y; Zheng Y
Oncol Rep; 2016 Oct; 36(4):1799-806. PubMed ID: 27499090
[TBL] [Abstract][Full Text] [Related]
9. Down-modulation of heat shock protein 70 and up-modulation of Caspase-3 during schisandrin B-induced apoptosis in human hepatoma SMMC-7721 cells.
Wu YF; Cao MF; Gao YP; Chen F; Wang T; Zumbika EP; Qian KX
World J Gastroenterol; 2004 Oct; 10(20):2944-8. PubMed ID: 15378770
[TBL] [Abstract][Full Text] [Related]
10. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin B stereoisomers protect against hypoxia/reoxygenation-induced apoptosis and associated changes in the Ca(2+)-induced mitochondrial permeability transition and mitochondrial membrane potential in AML12 hepatocytes.
Chiu PY; Luk KF; Leung HY; Ng KM; Ko KM
Phytother Res; 2009 Nov; 23(11):1592-602. PubMed ID: 19370538
[TBL] [Abstract][Full Text] [Related]
12. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
Shaik MS; Chatterjee A; Singh M
J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
[TBL] [Abstract][Full Text] [Related]
13. Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity.
Zhang Y; Zhou ZW; Jin H; Hu C; He ZX; Yu ZL; Ko KM; Yang T; Zhang X; Pan SY; Zhou SF
Drug Des Devel Ther; 2015; 9():2001-27. PubMed ID: 25926716
[TBL] [Abstract][Full Text] [Related]
14. Schisandrin B Attenuates Hepatic Stellate Cell Activation and Promotes Apoptosis to Protect against Liver Fibrosis.
Li Z; Zhao L; Xia Y; Chen J; Hua M; Sun Y
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833975
[TBL] [Abstract][Full Text] [Related]
15. Schisandrin B prevents doxorubicin-induced cardiotoxicity via enhancing glutathione redox cycling.
Li L; Pan Q; Han W; Liu Z; Li L; Hu X
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6753-60. PubMed ID: 18006777
[TBL] [Abstract][Full Text] [Related]
16. Proteinase-3, a serine protease which mediates doxorubicin-induced apoptosis in the HL-60 leukemia cell line, is downregulated in its doxorubicin-resistant variant.
Wu CH; Gordon J; Rastegar M; Ogretmen B; Safa AR
Oncogene; 2002 Aug; 21(33):5160-74. PubMed ID: 12140766
[TBL] [Abstract][Full Text] [Related]
17. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
[TBL] [Abstract][Full Text] [Related]
18. [Prevention against and treatment of doxorubicin-induced acute cardiotoxicity by dexrazoxane and schisandrin B].
Hu KY; Yang Y; He LH; Wang DW; Jia ZR; Li SR; Tian W; Mao J; Li XJ; Zhang W
Yao Xue Xue Bao; 2014 Jul; 49(7):1007-12. PubMed ID: 25233631
[TBL] [Abstract][Full Text] [Related]
19. Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.
Dai X; Yin C; Guo G; Zhang Y; Zhao C; Qian J; Wang O; Zhang X; Liang G
Toxicol Appl Pharmacol; 2018 Nov; 358():110-119. PubMed ID: 30195018
[TBL] [Abstract][Full Text] [Related]
20. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition.
Liu Z; Zhang B; Liu K; Ding Z; Hu X
PLoS One; 2012; 7(7):e40480. PubMed ID: 22848381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]